Calendar Companies Compare Analytics Learn Watchlist

Search CatalystAlert

Search for companies, drugs, and catalysts

Loading market movers...

Free biotech catalyst calendar tracking FDA decisions, clinical trial results, and PDUFA dates for biotech stocks.

Quick Links

Catalyst Calendar
Search Companies
Biotech Glossary
Therapeutic Areas

Legal

About
Privacy
Terms

Data Sources

ClinicalTrials.gov
SEC EDGAR
FDA

© 2025 CatalystAlert. All rights reserved.

Not financial advice. Data may be delayed or incomplete.

Aflibercept Injection - Phase 2 | 4151.T Pipeline | CatalystAlert

Aflibercept Injection

Phase 2

Kyowa Kirin Co., Ltd. (4151.T)

16%

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts

Aug 31

4151.TPhase 2Phase 2

Aflibercept Injection Phase 2 Results Expected

Aflibercept Injection • Diabetic Macular Edema (DME)

Drug Information

Target Indication

Diabetic Macular Edema (DME)

Clinical Trial

Last updated: 12/4/2025

Developer

4151.T

Kyowa Kirin Co., Ltd.

Biotechnology•North America•TSE